Hence, Ad5H2E-PPE1(3x)-ASMase pre-treatment reduces the iso-effective dose for 20–30% tumor cure by approximately 5.5 Gy from 20 Gy to 14.5 Gy. This evidence concerns the gene SMPD1 and neoplasm.